GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer
Condition: Locally Advanced or Metastatic Breast Cancer Interventions: Drug: GB491+ Fulvestrant; Drug: Placebo+Fulvestrant Sponsor: Genor Biopharma Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials